Is rifaximin-ciprofloxacin combination therapy effective in chronic active refractory pouchitis?
Rifaximin-ciprofloxacin combination therapy is safe and objectively effective in chronic active refractory pouchitis and may salvage a significant percentage of 'at risk pouches'.
Serum fetuin-A levels inversely correlated with advanced calcified coronary artery disease.